Inventor · disambiguated record
Thomas Lee
Also filed as: LEE THOMAS · LEE THOMAS T · LEE THOMAS T K · LEE THOMAS TUNG-YING
8 granted patents·127 citations·filing 1995–2017
87Inventor score
Top patents by PatentIndex Score
8 records- 0192US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 0292US6451340B1Nucleotide analog compositionsGILEAD SCIENCES INC·Filed 2001·Granted Sep 17, 2002·53 cites·47 claims
- 0388US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 0480US5726204ASuksdorfin analogs, compositions thereof, and methods for making and using thereofBIOTECH RESEARCH LAB INC·Filed 1995·Granted Mar 10, 1998·25 cites·32 claims
- 0579US5637589ASuksdorfin, analogs, compositions thereof, and methods for making and using thereofUNIV NORTH CAROLINA·Filed 1995·Granted Jun 10, 1997·24 cites·18 claims
- 0665US10052322B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2017·Granted Aug 21, 2018·0 cites·18 claims
- 0764US9827243B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2016·Granted Nov 28, 2017·0 cites·17 claims
- 0841US6319929B1Suksdorfin analogs, compositions thereof, and methods for making and using thereofUNIV NORTH CAROLINA·Filed 1998·Granted Nov 20, 2001·2 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →